Aldactide and dytide
Author information unavailable
Abstract
Author information unavailable
Abstract
Aldactide tablets (Searle) contain a thiazide diuretic (hydroflumethiazide, 25 mg) together with an aldosterone antagonist (spironolactone, 25 mg). The manufacturers recommend this mixture for the treatment of oedema and essential hypertension. The potassium-sparing effect of Aldactide is similar to that of Dytide (SKF), a mixture of benzthiazide (25 mg) and triamterene (50 mg), although triamterene,1 unlike spironolactone, does not antagonise aldosterone.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aldactide tablets (Searle) contain a thiazide diuretic (hydroflumethiazide, 25 mg) together with an aldosterone antagonist (spironolactone, 25 mg). The manufacturers recommend this mixture for the treatment of oedema and essential hypertension. The potassium-sparing effect of Aldactide is similar to that of Dytide (SKF), a mixture of benzthiazide (25 mg) and triamterene (50 mg), although triamterene,1 unlike spironolactone, does not antagonise aldosterone.
Key concepts: Triamterene, Spironolactone, Aldosterone, Diuretic, Potassium, Pharmacology, Chemistry, Antagonist